Skip to main content

Labcorp ownership: holders and insider trading

  • LH · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$370.48−0.49%Close 13 Nov 2026 · Market value $30.04B

As filed, its directors and officers own 0.8% of the shares (proxy statement, 26 Mar 2026); 1,043 institutional managers reported holding 97.9% at 30 Jun 2026. Over the last twelve months, insiders sold $10.41M of shares on the open market, $6.67M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
VanguardInstitution9.9M12.18%*Form 13F30 Jun 2026
BLACKROCK, INC.Holder6.6M8.10%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder6.2M7.52%Schedule 13G31 Mar 2026
Victory Capital Management IncInstitution4.8M5.96%*Form 13F30 Jun 2026
State StreetInstitution3.9M4.81%*Form 13F30 Jun 2026
Boston PartnersInstitution3.1M3.76%*Form 13F30 Jun 2026
Allspring Global Investments Holdings, LLCInstitution2.2M2.75%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution2.2M2.70%*Form 13F30 Jun 2026
Select Equity Group, L.P.Institution2.0M2.44%*Form 13F30 Jun 2026
Fidelity (FMR)Institution1.9M2.35%*Form 13F30 Jun 2026
Morgan StanleyInstitution1.6M1.98%*Form 13F30 Jun 2026
UBSInstitution1.4M1.73%*Form 13F30 Jun 2026
Dimensional Fund AdvisorsInstitution1.4M1.68%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution1.3M1.56%*Form 13F30 Jun 2026
InvescoInstitution1.2M1.52%*Form 13F30 Jun 2026
Nordea Investment Management ABInstitution916K1.13%*Form 13F30 Jun 2026
Northern TrustInstitution883K1.09%*Form 13F30 Jun 2026
Wellington ManagementInstitution856K1.05%*Form 13F30 Jun 2026
American Century Companies IncInstitution845K1.04%*Form 13F30 Jun 2026
Bank of AmericaInstitution812K1.00%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
ANDERSON KERRII B · Director17 Aug 2026Open-market sale (10b5-1 plan)−3.0K$318.02$954.1K
Schechter Adam H · President & CEO · Director11 Aug 2026Open-market sale (10b5-1 plan)−4.7K$320.37$1.50M
Summy Amy B. · EVP, Chief Marketing Officer4 Aug 2026Open-market sale−924$306.74$283.4K
Wilkinson Peter J · SVP, Chief Accounting Officer3 Aug 2026Open-market sale−1.3K$309.23$413.7K
Wilkinson Peter J · SVP, Chief Accounting Officer3 Aug 2026Option exercise+1.3K$209.25$280.0K
Wilkinson Peter J · SVP, Chief Accounting Officer3 Aug 2026Open-market sale−82$309.22$25.36K
Kyle Kathryn W · EVP, Chief Legal Officer2 Jul 2026Open-market sale (10b5-1 plan)−92$286.19$26.33K
Vaughn Bryan T · EVP and President, Diagnostics2 Jul 2026Open-market sale (10b5-1 plan)−234$286.19$66.97K
Kyle Kathryn W · EVP, Chief Legal Officer1 Jul 2026Option exercise+256——
Kyle Kathryn W · EVP, Chief Legal Officer1 Jul 2026Shares withheld for tax−73$283.88$20.72K
Vaughn Bryan T · EVP and President, Diagnostics1 Jul 2026Shares withheld for tax−93$283.88$26.40K
Vaughn Bryan T · EVP and President, Diagnostics1 Jul 2026Option exercise+327——
Kyle Kathryn W · EVP, Chief Legal Officer8 Jun 2026Open-market sale (10b5-1 plan)−762$263.89$201.1K
Schechter Adam H · President & CEO · Director11 May 2026Open-market sale (10b5-1 plan)−5.9K$254.50$1.50M
Wilkinson Peter J · SVP, Chief Accounting Officer27 Mar 2026Open-market sale (10b5-1 plan)−1.6K$267.05$436.1K
Meltzer Jonathan C · EVP, Operations27 Mar 2026Open-market sale (10b5-1 plan)−839$267.05$224.1K
Schechter Adam H · President & CEO · Director26 Mar 2026Shares withheld for tax−26.1K$268.38$7.01M
Schechter Adam H · President & CEO · Director26 Mar 2026Grant or award+58.5K——
GRAHAM ANITA Z · EVP, CHRO26 Mar 2026Grant or award+6.6K——
GRAHAM ANITA Z · EVP, CHRO26 Mar 2026Shares withheld for tax−2.9K$268.38$772.7K
Schroeder Mark S · EVP, Pres Diagnostics & COO26 Mar 2026Shares withheld for tax−1.5K$268.38$394.0K
Schroeder Mark S · EVP, Pres Diagnostics & COO26 Mar 2026Grant or award+3.0K——
Schroeder Mark S · EVP, Pres Diagnostics & COO26 Mar 2026Shares withheld for tax−4.6K$268.38$1.23M
Schroeder Mark S · EVP, Pres Diagnostics & COO26 Mar 2026Grant or award+9.3K——
Caveney Brian J · EVP, Pres of ED, CMO & CSO26 Mar 2026Grant or award+9.3K——

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

LH in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.